This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Contraception, Postcoital
and you are
between 18 and 35
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

In this study the effect of piroxicam on the ovulation will be evaluated. Therefore piroxicam will be administered as a single-dose after onset of LH surge (luteinizing hormone, hormone which triggers ovulation). Additionally blood levels of endogenous hormones (hormones produced by your body) will be measured and transvaginal ultrasound examinations will be conducted at regular intervals. In addition the concentration of piroxicam in blood will be determined in regular intervals. With regards to the tolerability of the study drug subjects will be asked regularly how they feel.

Provided treatments

  • Drug: Piroxicam ( BAYl1902)
  • Drug: Piroxicam ( BAYl1902)
  • Drug: Placebo
  • Drug: Piroxicam ( BAYl1902)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01320709. The sponsor of the trial is Bayer and it is looking for 72 volunteers for the current phase.
Official trial title:
Single-center, Randomized, Placebo-controlled, Double-blind, Parallel Group Study to Evaluate Whether a Single-dose of Either 20 mg Piroxicam, 40 mg Piroxicam or 80 mg Piroxicam Shows an Effect on Ovulation After the Onset of LH Surge Compared to Placebo in Healthy Young Women